Fig. 4: Progression Free Survival (PFS).
The median PFS with frontline therapy was 4.2 years for the NCPF-Enriched cohort compared to 2.6 years for the NCPF-Low cohort [hazard ratio 0.64, p = 0.006].
Fig. 4: Progression Free Survival (PFS). | Blood Cancer Journal
